Venetoclax; Rituximab clinical trials

Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia

This study is testing a new, chemotherapy-free treatment for Waldenström's macroglobulinemia (WM). It combines two drugs, Venetoclax and Rituximab, to see if they work better than traditional chemotherapy for people newly diagnosed with WM.